Wednesday, 2 December 2026 | 15:30 - 16:35
Session 3: Vaccination of Immunocompromised Patients
15:30 Vaccination for vulnerable patients - Stephanie Humblet-Baron, MD, PhD, Associate Professor, The Rega Institute, KU Leuven
This presentation will explore how a systems vaccinology approach can be used to investigate vaccine responses in immunodeficient patients.
15:50 Vaccinations for the immunocompromised traveler – Dr. Jelle Visser, Institute of Tropical Medicine and Antwerp University Hospital
This lecture will address routine and travel vaccinations for immunocompromised travelers, including patients receiving immunosuppressive treatment. Through practical case examples, it will cover live and non-live vaccines, contraindications, vaccination timing in relation to immunosuppressive treatment, and the practical organisation of a pre-travel consultation.
16:10 ImmunoVax: the last mile for vaccinations - Prof. dr. Steven Callens, Head of Department of General Internal Medicine and Infectious Diseases, Ghent University Hospital; Co-founder (together with Tom Van Varenbergh) and CMO, ImmunoVax
Vaccination advice for immunocompromised patients is spread over many national and international guidelines that are hard to apply in daily practice. ImmunoVax is an AI-based decision support tool, currently in development, that translates these guidelines into dynamic patient-specific, traceable vaccination recommendations for clinicians.
16:20 Q&A
3 speakers
Head of Department General Internal Medicine Ghent University Hospital
Ghent University Hospital
Associate Professor
KU Leuven
Internist and infectious diseases specialist, Institute of Tropical Medicine, Antwerp
Institute of Tropical Medicine